vs
Primis Financial Corp.（FRST）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Primis Financial Corp.的1.5倍（$69.8M vs $45.6M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 16.0%，领先368.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.0%）
Primis金融集团是一家总部位于美国的金融控股公司，运营多家全服务银行子公司，面向个人及企业客户提供存款、贷款、按揭、财富管理等多元化金融服务，核心业务覆盖美国中大西洋沿岸区域。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FRST vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$45.6M
净利率更高
RIGL
高出368.0%
16.0%
两年增速更快
RIGL
近两年复合增速
13.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.6M | $69.8M |
| 净利润 | $7.3M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | — | 33.2% |
| 净利率 | 16.0% | 384.0% |
| 营收同比 | — | 21.2% |
| 净利润同比 | 200.0% | 1769.2% |
| 每股收益（稀释后） | $0.30 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FRSTRIGL
| Q1 26 | $45.6M | — | ||
| Q4 25 | $80.9M | $69.8M | ||
| Q3 25 | $41.0M | $69.5M | ||
| Q2 25 | $43.2M | $101.7M | ||
| Q1 25 | $58.7M | $53.3M | ||
| Q4 24 | $38.8M | $57.6M | ||
| Q3 24 | $37.3M | $55.3M | ||
| Q2 24 | $35.7M | $36.8M |
净利润FRSTRIGL
| Q1 26 | $7.3M | — | ||
| Q4 25 | $29.5M | $268.1M | ||
| Q3 25 | $6.8M | $27.9M | ||
| Q2 25 | $2.4M | $59.6M | ||
| Q1 25 | $22.6M | $11.4M | ||
| Q4 24 | $-26.2M | $14.3M | ||
| Q3 24 | $1.2M | $12.4M | ||
| Q2 24 | $3.4M | $-1.0M |
毛利率FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 44.8% | 33.2% | ||
| Q3 25 | 21.3% | 40.9% | ||
| Q2 25 | 6.9% | 60.1% | ||
| Q1 25 | 41.9% | 23.9% | ||
| Q4 24 | -123.0% | 28.9% | ||
| Q3 24 | -3.1% | 25.4% | ||
| Q2 24 | 7.8% | 1.2% |
净利率FRSTRIGL
| Q1 26 | 16.0% | — | ||
| Q4 25 | 36.5% | 384.0% | ||
| Q3 25 | 16.7% | 40.2% | ||
| Q2 25 | 5.6% | 58.6% | ||
| Q1 25 | 38.6% | 21.5% | ||
| Q4 24 | -100.3% | 24.9% | ||
| Q3 24 | 3.3% | 22.5% | ||
| Q2 24 | 9.6% | -2.8% |
每股收益（稀释后）FRSTRIGL
| Q1 26 | $0.30 | — | ||
| Q4 25 | $1.19 | $14.11 | ||
| Q3 25 | $0.28 | $1.46 | ||
| Q2 25 | $0.10 | $3.28 | ||
| Q1 25 | $0.92 | $0.63 | ||
| Q4 24 | $-0.95 | $0.82 | ||
| Q3 24 | $0.05 | $0.70 | ||
| Q2 24 | $0.14 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $159.9M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $427.2M | $391.5M |
| 总资产 | $4.3B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FRSTRIGL
| Q1 26 | $159.9M | — | ||
| Q4 25 | $143.6M | $155.0M | ||
| Q3 25 | $63.9M | $137.1M | ||
| Q2 25 | $94.1M | $108.4M | ||
| Q1 25 | $57.0M | $77.1M | ||
| Q4 24 | $64.5M | $77.3M | ||
| Q3 24 | $77.3M | $61.1M | ||
| Q2 24 | $66.6M | $49.1M |
总债务FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M |
股东权益FRSTRIGL
| Q1 26 | $427.2M | — | ||
| Q4 25 | $422.9M | $391.5M | ||
| Q3 25 | $382.2M | $117.6M | ||
| Q2 25 | $376.4M | $81.9M | ||
| Q1 25 | $375.6M | $18.6M | ||
| Q4 24 | $351.8M | $3.3M | ||
| Q3 24 | $381.0M | $-14.6M | ||
| Q2 24 | $376.0M | $-29.9M |
总资产FRSTRIGL
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.0B | $513.6M | ||
| Q3 25 | $4.0B | $242.5M | ||
| Q2 25 | $3.9B | $206.7M | ||
| Q1 25 | $3.7B | $176.0M | ||
| Q4 24 | $3.7B | $164.0M | ||
| Q3 24 | $4.0B | $139.4M | ||
| Q2 24 | $4.0B | $128.4M |
负债/权益比FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | $10.8M | $22.0M | ||
| Q3 25 | $-11.4M | $24.0M | ||
| Q2 25 | $-41.0M | $30.5M | ||
| Q1 25 | $34.4M | $-893.0K | ||
| Q4 24 | $19.5M | $14.5M | ||
| Q3 24 | $6.1M | $21.7M | ||
| Q2 24 | $52.3M | $302.0K |
自由现金流FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | $9.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $18.3M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 11.2% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — |
现金转化率FRSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 0.36× | 0.08× | ||
| Q3 25 | -1.67× | 0.86× | ||
| Q2 25 | -16.82× | 0.51× | ||
| Q1 25 | 1.52× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 4.93× | 1.75× | ||
| Q2 24 | 15.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FRST
| Net Interest Income | $32.1M | 70% |
| Noninterest Income | $13.6M | 30% |
RIGL
暂无分部数据
